Treating refractory scleritis with infliximab

被引:21
作者
Ahn, Seong Joon [1 ,2 ]
Oh, Joo Youn [1 ,2 ]
Kim, Mee Kum [1 ,2 ]
Wee, Won Ryang [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Clin Res Inst, Seoul Artificial Eye Ctr, Seoul 110744, South Korea
关键词
infliximab; scleritis; tumor necrosis factor alpha;
D O I
10.1007/s10384-008-0652-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:286 / 287
页数:2
相关论文
共 5 条
[1]   Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation [J].
Galor, Anat ;
Perez, Victor L. ;
Hammel, Jeffrey P. ;
Lowder, Careen Y. .
OPHTHALMOLOGY, 2006, 113 (12) :2317-2323
[2]   Biologic agents in the management of inflammatory eye diseases [J].
Michalova, Kira ;
Lim, Lyndell .
CURRENT ALLERGY AND ASTHMA REPORTS, 2008, 8 (04) :339-347
[3]  
Smith JR, 2001, ARTHRIT RHEUM-ARTHR, V45, P252, DOI 10.1002/1529-0131(200106)45:3<252::AID-ART257>3.0.CO
[4]  
2-5
[5]   Infliximab therapy for the treatment of refractory ocular inflammatory disease [J].
Sobrin, Lucia ;
Kim, Eva C. ;
Christen, William ;
Papadaki, Thekla ;
Letko, Erik ;
Foster, C. Stephen .
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (07) :895-900